Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shan Sun, Kai Chen, Xuehua Kong, Wenjun Tian & Siqiang Niu. (2022) Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant Enterobacterales: A Multi-Center Study in Southwest China. Infection and Drug Resistance 15, pages 2243-2251.
Read now
Read now
Worapong Nasomsong, Parnrada Nulsopapon, Dhitiwat Changpradub, Manat Pongchaidecha, Supanun Pungcharoenkijkul, Piraporn Juntanawiwat, Waristha Simsiriporn & Wichai Santimaleeworagun. (2021) The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital. Drug Design, Development and Therapy 15, pages 3095-3104.
Read now
Read now
Yanhui Ding, Huijuan Wang, Shuli Pu, Shifeng Huang & Siqiang Niu. (2021) Resistance Trends of Klebsiella pneumoniae Causing Urinary Tract Infections in Chongqing, 2011–2019. Infection and Drug Resistance 14, pages 475-481.
Read now
Read now
Articles from other publishers (6)
Rawan Taha, Ola Kader, Sherine Shawky & Shahinda Rezk. (2023) Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope. Annals of Clinical Microbiology and Antimicrobials 22:1.
Crossref
Crossref
Pan Fu, Xinpeng Luo, Jun shen, Leiyan He, Hua Rong, Chunling Li, Saige Chen, Lei Zhang, Aimin Wang & Chuanqing Wang. (2023) The molecular and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae isolated from children in Shanghai, China, 2016–2021. Journal of Microbiology, Immunology and Infection 56:1, pages 48-56.
Crossref
Crossref
Priya Sreenivasan, Bhawna Sharma, Satinder Kaur, Sudesh Rana, Manisha Biswal, Pallab Ray & Archana Angrup. (2022) In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era. The Journal of Antibiotics 75:8, pages 454-462.
Crossref
Crossref
Dongna Zou, Guangyue Yao, Chengwu Shen, Jinru Ji, Chaoqun Ying, Peipei Wang, Zhiying Liu, Jun Wang, Yan Jin & Yonghong Xiao. (2021) The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China. Frontiers in Microbiology 12.
Crossref
Crossref
Ivan Cervino, Deborah Gonzalez, Marcela Nastro, Juana Vega, Ana Paula Reyes, Gisella Buriano, Carlos Vay, Angela Famiglietti & Carlos Hernan Rodriguez. (2021) In vitro synergistic activity of aztreonam (AZT) plus novel and old β-lactamase inhibitor combinations against metallo-β-lactamase-producing AZT-resistant Enterobacterales. Journal of Medical Microbiology 70:10.
Crossref
Crossref
Carola Mauri, Alberto Enrico Maraolo, Stefano Di Bella, Francesco Luzzaro & Luigi Principe. (2021) The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases. Antibiotics 10:8, pages 1012.
Crossref
Crossref